We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is MO Stock a Buy Now as Earnings Strength Meets Valuation Pressure?
Read MoreHide Full Article
Key Takeaways
Altria's smokeable earnings rose 3.9% in Q3 2026, supported by pricing gains and disciplined cost control.
MO's cigarette shipments fell 2.9%, while Marlboro's retail share declined to 39.5% amid discount pressure.
MO trades at 13.01X forward earnings, near its five-year high, as smoke-free execution remains uneven.
Altria Group, Inc. (MO - Free Report) continues to pair earnings growth and substantial shareholder returns with a shrinking cigarette market. Pricing discipline and cost control are protecting profitability, but the stock’s valuation now sits near the upper end of its five-year range.
That creates a more balanced investment question. Resilient profits support the case for the shares, while cigarette-volume pressure and uneven smoke-free execution leave less room for operational disappointment at the current multiple.
Altria Group, Inc. Price, Consensus and EPS Surprise
MO's Core Business Still Generates Earnings Growth
Altria’s smokeable products business remains the main earnings engine. Adjusted operating companies income rose 3.9% to $3.07 billion in the third quarter of 2026, while adjusted margin increased 10 basis points to 64.5%.
For the first nine months, adjusted smokeable operating companies income advanced 4.1% and margin improved 40 basis points to 64.8%. A 4.4% third-quarter price realization helped offset lower shipments and an unfavorable shift toward discount products, showing how pricing and cost discipline continue to support earnings.
Altria Faces a Persistent Cigarette Volume Problem
The durability of that model still depends on managing structural volume declines. Reported domestic cigarette shipments fell 2.9% in the third quarter and declined an estimated 4% after adjusting for trade inventory movements.
Marlboro’s retail share of the total cigarette category fell 1 percentage point year over year to 39.5%. At the same time, the industry’s discount retail share rose 2 percentage points to 34.1%, reflecting continued discretionary-income pressure on adult smokers and increasing the risk of an unfavorable mix.
MO's Smoke-Free Transition Is Still Uneven
Altria is gaining volume in nicotine pouches, but the competitive picture remains mixed. on! shipments increased 13.3% to 47.8 million cans in the third quarter, yet its share of the nicotine pouch category declined 1.3 percentage points to 13.5%.
Oral Tobacco Products adjusted operating companies income fell 3.7% to $443 million, while NJOY ACE remained absent from the U.S. market. The competitive backdrop is also intensifying. Philip Morris International Inc. (PM - Free Report) reported continued U.S. expansion of ZYN, while British American Tobacco p.l.c. (BTI - Free Report) has been building its Velo nicotine-pouch presence and planned a broader U.S. rollout of Velo Max in the second half of 2026.
Altria's Valuation Creates a Key Trade-Off
MO trades at 13.01X forward 12-month earnings, below 15.86X for the Zacks sub-industry, 18.09X for the Zacks sector and 18.05X for the S&P 500 index. On a relative basis, the shares still look less expensive than those benchmarks.
The stock’s own history is less forgiving. Its current multiple is above the five-year median of 9.82X and close to the five-year high of 13.46X. That suggests investors are already assigning meaningful value to Altria’s earnings resilience, reducing the margin for disappointment if volume or smoke-free execution weakens.
Image Source: Zacks Investment Research
MO's Ratings Favor Cautious Optimism
For investors assessing MO now, the evidence supports cautious optimism rather than an unqualified buy case. Earnings remain resilient and valuation is still below broader comparisons, but the stock’s historical multiple and operating risks make entry price and execution increasingly important.
MO currently carries a Zacks Rank #2 (Buy), a constructive short-term signal tied to earnings-estimate revisions. Its Style Scores are less supportive, with a Value Score of D, Growth Score of C, Momentum Score of F and VGM Score of F. Because the Style Scores are designed to complement the Zacks Rank, that combination points to a favorable earnings-revision backdrop but a weaker overall profile across value, growth and momentum characteristics. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image: Bigstock
Is MO Stock a Buy Now as Earnings Strength Meets Valuation Pressure?
Key Takeaways
Altria Group, Inc. (MO - Free Report) continues to pair earnings growth and substantial shareholder returns with a shrinking cigarette market. Pricing discipline and cost control are protecting profitability, but the stock’s valuation now sits near the upper end of its five-year range.
That creates a more balanced investment question. Resilient profits support the case for the shares, while cigarette-volume pressure and uneven smoke-free execution leave less room for operational disappointment at the current multiple.
Altria Group, Inc. Price, Consensus and EPS Surprise
Altria Group, Inc. price-consensus-eps-surprise-chart | Altria Group, Inc. Quote
MO's Core Business Still Generates Earnings Growth
Altria’s smokeable products business remains the main earnings engine. Adjusted operating companies income rose 3.9% to $3.07 billion in the third quarter of 2026, while adjusted margin increased 10 basis points to 64.5%.
For the first nine months, adjusted smokeable operating companies income advanced 4.1% and margin improved 40 basis points to 64.8%. A 4.4% third-quarter price realization helped offset lower shipments and an unfavorable shift toward discount products, showing how pricing and cost discipline continue to support earnings.
Altria Faces a Persistent Cigarette Volume Problem
The durability of that model still depends on managing structural volume declines. Reported domestic cigarette shipments fell 2.9% in the third quarter and declined an estimated 4% after adjusting for trade inventory movements.
Marlboro’s retail share of the total cigarette category fell 1 percentage point year over year to 39.5%. At the same time, the industry’s discount retail share rose 2 percentage points to 34.1%, reflecting continued discretionary-income pressure on adult smokers and increasing the risk of an unfavorable mix.
MO's Smoke-Free Transition Is Still Uneven
Altria is gaining volume in nicotine pouches, but the competitive picture remains mixed. on! shipments increased 13.3% to 47.8 million cans in the third quarter, yet its share of the nicotine pouch category declined 1.3 percentage points to 13.5%.
Oral Tobacco Products adjusted operating companies income fell 3.7% to $443 million, while NJOY ACE remained absent from the U.S. market. The competitive backdrop is also intensifying. Philip Morris International Inc. (PM - Free Report) reported continued U.S. expansion of ZYN, while British American Tobacco p.l.c. (BTI - Free Report) has been building its Velo nicotine-pouch presence and planned a broader U.S. rollout of Velo Max in the second half of 2026.
Altria's Valuation Creates a Key Trade-Off
MO trades at 13.01X forward 12-month earnings, below 15.86X for the Zacks sub-industry, 18.09X for the Zacks sector and 18.05X for the S&P 500 index. On a relative basis, the shares still look less expensive than those benchmarks.
The stock’s own history is less forgiving. Its current multiple is above the five-year median of 9.82X and close to the five-year high of 13.46X. That suggests investors are already assigning meaningful value to Altria’s earnings resilience, reducing the margin for disappointment if volume or smoke-free execution weakens.
Image Source: Zacks Investment Research
MO's Ratings Favor Cautious Optimism
For investors assessing MO now, the evidence supports cautious optimism rather than an unqualified buy case. Earnings remain resilient and valuation is still below broader comparisons, but the stock’s historical multiple and operating risks make entry price and execution increasingly important.
MO currently carries a Zacks Rank #2 (Buy), a constructive short-term signal tied to earnings-estimate revisions. Its Style Scores are less supportive, with a Value Score of D, Growth Score of C, Momentum Score of F and VGM Score of F. Because the Style Scores are designed to complement the Zacks Rank, that combination points to a favorable earnings-revision backdrop but a weaker overall profile across value, growth and momentum characteristics. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.